Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer

Clinical trial NCT00499668 · WITHDRAWN

Trial details

NCT number: NCT00499668
Sponsor: Vanderbilt-Ingram Cancer Center
Status: WITHDRAWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Myeloproliferative Disorders Leukemia Lymphoma Lymphoproliferative Disorder Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Nausea and Vomiting Solid Tumor

Start date: 2007-08-01
Primary completion: 2008-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.